Correlation Between PT UBC and Chandra Asri

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PT UBC and Chandra Asri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT UBC and Chandra Asri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT UBC Medical and Chandra Asri Petrochemical, you can compare the effects of market volatilities on PT UBC and Chandra Asri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT UBC with a short position of Chandra Asri. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT UBC and Chandra Asri.

Diversification Opportunities for PT UBC and Chandra Asri

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between LABS and Chandra is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding PT UBC Medical and Chandra Asri Petrochemical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chandra Asri Petroch and PT UBC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT UBC Medical are associated (or correlated) with Chandra Asri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chandra Asri Petroch has no effect on the direction of PT UBC i.e., PT UBC and Chandra Asri go up and down completely randomly.

Pair Corralation between PT UBC and Chandra Asri

Assuming the 90 days trading horizon PT UBC Medical is expected to generate 0.46 times more return on investment than Chandra Asri. However, PT UBC Medical is 2.16 times less risky than Chandra Asri. It trades about -0.03 of its potential returns per unit of risk. Chandra Asri Petrochemical is currently generating about -0.12 per unit of risk. If you would invest  13,900  in PT UBC Medical on September 5, 2024 and sell it today you would lose (500.00) from holding PT UBC Medical or give up 3.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.41%
ValuesDaily Returns

PT UBC Medical  vs.  Chandra Asri Petrochemical

 Performance 
       Timeline  
PT UBC Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PT UBC Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, PT UBC is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Chandra Asri Petroch 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chandra Asri Petrochemical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

PT UBC and Chandra Asri Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PT UBC and Chandra Asri

The main advantage of trading using opposite PT UBC and Chandra Asri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT UBC position performs unexpectedly, Chandra Asri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chandra Asri will offset losses from the drop in Chandra Asri's long position.
The idea behind PT UBC Medical and Chandra Asri Petrochemical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets